Lignocaine use in respiratory viruses

Abstract

Following the publication of the article entitled, ‘Lignocaine’s substantial role in COVID-19 management: potential remedial and therapeutic implications’, authored by Nasser Ali Malik, Amjid Hammodi and Dayanidhi Jaiswara, published in the Anaesthesia, Pain and Intensive Care; 21(1);59-63, 2020, I would like to suggest a revolutionary idea that could help control the spread of respiratory viruses from person to person, achieve potential prophylaxis against them and even could be used as a treatment for mild to moderately infected cases.